Key facts
- ShiftMed’s last known valuation is $1.0B (May 2024).
- It has raised $404.9M; the latest was Debt - General ($3.0M) in Apr 2025.
- Notable investors include TEDCO, Blue Heron Capital, Audacious Capital, 3TS Capital Partners, BIP Ventures — 10 tracked in total.
- 1 investment vehicle was formed to buy ShiftMed shares in the last 12 months, reporting $1.5M sold to 43 investors, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for ShiftMed
- ·The full record, as it builds
Funding rounds
No funding rounds for ShiftMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy ShiftMed shares, reporting $1.5M sold to 43 investors. Most recent filing Apr 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About ShiftMed
Developer of a staffing platform designed to connect providers and healthcare professionals. The company allows posting staffing needs by location, time, and type of care through a convenient portal, where shifts will be instantly available for the network of healthcare professionals to claim, enabling families to interview, hire, and manage fully credentialed, insured, and bonded caregivers.
- Sector
- Healthcare
- HQ
- McLean, VA, United States
- Founded
- 2014
- Employees
- 267
- Website
- shiftmed.com/
- Ownership
- Privately Held (backing)
ShiftMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ShiftMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ShiftMed in its N-PORT filings yet. We sweep new filings monthly.